相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current role of antibody therapy in patients with metastatic colorectal cancer
P. Pfeiffer et al.
ONCOGENE (2007)
The clinical significance of circulating tumor cells in the peripheral blood
Yahya I. Elshimali et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer
Mizutomo Azuma et al.
CLINICAL COLORECTAL CANCER (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
Steven J. Cohen et al.
CLINICAL COLORECTAL CANCER (2006)
Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer
Moritz Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors
Hongbin Ji et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Impact of disseminated tumor cells in gastrointestinal cancer
Stefan Thorban et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies
Wu Zhang et al.
ANNALS OF MEDICINE (2006)
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites:: biological and clinical implications
A Italiano et al.
ANNALS OF ONCOLOGY (2005)
Loss of epidermal growth factor receptor expression in lymph node and liver metastases of colon carcinoma
MP Bralet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report
P Nygren et al.
ACTA ONCOLOGICA (2005)
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
KY Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: Implications for treatment with EGFR-targeted monoclonal antibodies
M Scartozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Molecular detection of circulating cancer cells - Role in diagnosis, prognosis and follow-up of colon cancer patients
B Molnar et al.
DIGESTIVE DISEASES (2003)
Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer
U Guller et al.
ANNALS OF SURGERY (2002)
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis
H Ge et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
